Streetbeat News

Analyst Ratings

VST

Morgan Stanley analyst Stephen Byrd has maintained an Overweight rating on Vistra (NYSE:VST) and raised the price target from $32 to $33.

Portfolio Pulse from Benzinga Newsdesk

July 21, 2023 | 3:21 pm

VIR

Morgan Stanley analyst Michelle Gilson has maintained an Equal-Weight rating on Vir Biotechnology (NASDAQ:VIR) but lowered the price target from $27 to $15.

Portfolio Pulse from Benzinga Newsdesk

July 21, 2023 | 3:20 pm

UAL

Morgan Stanley analyst Ravi Shanker maintains an Overweight rating on United Airlines Holdings (NASDAQ:UAL) and raises the price target from $75 to $80.

Portfolio Pulse from Benzinga Newsdesk

July 21, 2023 | 3:19 pm

USB

Morgan Stanley analyst Betsy Graseck maintains an Equal-Weight rating on U.S. Bancorp (NYSE:USB) and raises the price target from $42 to $45.

Portfolio Pulse from Benzinga Newsdesk

July 21, 2023 | 3:18 pm

JPM

A whale investor has taken a bullish stance on JPMorgan Chase (NYSE:JPM), with 50% of the investors opening trades with bullish expectations and 50% with bearish. The whale has been targeting a price range from $85.0 to $160.0 for JPMorgan Chase over the last 3 months. The current price of JPM is down -0.69% at $155.07. RSI indicators suggest that the stock may be overbought. The next earnings are expected to be released in 84 days.

Portfolio Pulse from Benzinga Insights

July 21, 2023 | 3:17 pm

CVS

A significant bearish stance has been taken on CVS Health (NYSE:CVS) by a large investor, as indicated by a large position in options. The sentiment among these big-money traders is 30% bullish and 70% bearish. The targeted price range for CVS Health over the last 3 months is $70.0 to $77.5. The current price of CVS is $75.12, up 0.33%. JP Morgan, Barclays, and Mizuho have maintained their positive ratings on CVS Health, with price targets of $106, $89, and $88 respectively.

Portfolio Pulse from Benzinga Insights

July 21, 2023 | 3:17 pm

TFC

Morgan Stanley analyst Betsy Graseck has maintained an Equal-Weight rating on Truist Financial (TFC) but lowered the price target from $42 to $41.

Portfolio Pulse from Benzinga Newsdesk

July 21, 2023 | 3:17 pm

LYV

Shares of Live Nation Entertainment Inc (NYSE:LYV) have climbed more than 40% year to date. Analyst Jed Kelly from Oppenheimer initiated coverage of Live Nation Entertainment with an Outperform rating and a price target of $110. Kelly noted that the company's breadth of inventory is well positioned to deliver more events to a wider network of fans and is likely to benefit from music streaming advancements. Live Nation's proactive partnership with legislators on fair ticketing initiatives is expected to reduce the likelihood of a negative regulatory outcome.

Portfolio Pulse from Priya Nigam

July 21, 2023 | 3:14 pm

AMD

NVDA

TSM

AMD is reportedly exploring alternatives to its production and partner foundries to reduce reliance on TSMC. CEO Lisa Su expressed openness to leveraging TSMC sites outside Taiwan and highlighted the significant opportunity in AI with GPUs. BofA analyst Vivek Arya cut his price target for AMD to $130 from $135, citing pressure from NVDA's full-stack AI platform on AMD data center GPU market share.

Portfolio Pulse from Anusuya Lahiri

July 21, 2023 | 3:14 pm

TRV

Morgan Stanley analyst Michael Phillips has reiterated an Equal-Weight rating on Travelers Companies (NYSE:TRV) and maintained a price target of $185.

Portfolio Pulse from Benzinga Newsdesk

July 21, 2023 | 3:13 pm